Obstructive sleep apnea (OSA) and clinical depression—prevalence in a sleep center

Acker, Jens; Richter, Kneginja; Piehl, Anja; Herold, J.; Ficker, Joachim H.; Niklewski, Günter

doi:10.1007/s11325-016-1411-3

Cited by 37 publications

(21 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We found that 3 months of CPAP treatment of patients with OSA had a beneficial effect on the level of depressive and trait anxiety symptoms (Acker et al, 2017;BaHammam et al, 2016;Ejaz et al, 2011;Fidan et al, 2007;Naqvi et al, 2014;Ryan, Bayley, Green, Murray, & Bradley, 2011;Sanchez, Buela-Casal, Bermudez, & Casas-Maldonado, 2001). These effects were highly significant, because they survived Bonferroni correction.…”

Section: Discussionmentioning

confidence: 73%

“…Higher depression is caused by daytime sleepiness, and the resulting fatigue and, vice‐versa, higher level of depressive symptoms can be understood as a risk factor in the development of EDS (Aloia et al, ; Antic et al, ). We found that 3 months of CPAP treatment of patients with OSA had a beneficial effect on the level of depressive and trait anxiety symptoms (Acker et al, ; BaHammam et al, ; Ejaz et al, ; Fidan et al, ; Naqvi et al, ; Ryan, Bayley, Green, Murray, & Bradley, ; Sanchez, Buela‐Casal, Bermudez, & Casas‐Maldonado, ). These effects were highly significant, because they survived Bonferroni correction.…”

Section: Discussionmentioning

confidence: 98%

“…On the other hand, cognitive impairment may be a consequence of EDS due to sleep fragmentation (Zhou et al, 2016). In the context of mood disorders with OSA, a higher degree of depressive and anxiety symptoms is frequently described (Acker et al, 2017;Cai, Xu, Wei, Sun, & Chen, 2017;Ejaz, Khawaja, Bhatia, & Hurwitz, 2011;Schroder & ÓHara, 2005). Depression in particular is closely linked with OSA due to common clinical symptoms (Acker et al, 2017;BaHammam et al, 2016;Ejaz et al, 2011;Fidan, Unlu, Sezer, Gecici, & Kara, 2007;Naqvi et al, 2014).…”

mentioning

confidence: 99%

“…In the context of mood disorders with OSA, a higher degree of depressive and anxiety symptoms is frequently described (Acker et al, 2017;Cai, Xu, Wei, Sun, & Chen, 2017;Ejaz, Khawaja, Bhatia, & Hurwitz, 2011;Schroder & ÓHara, 2005). Depression in particular is closely linked with OSA due to common clinical symptoms (Acker et al, 2017;BaHammam et al, 2016;Ejaz et al, 2011;Fidan, Unlu, Sezer, Gecici, & Kara, 2007;Naqvi et al, 2014). Both neuropsychiatric consequences of OSA, cognitive dysfunction and mood changes, may also be affected by frequently described co-morbidities, such as hypertension or diabetes (Fidan et al, 2007).…”

mentioning

confidence: 99%

See 3 more Smart Citations

Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea

Dostálová

Kolečkárová

Kuška

et al. 2018

Journal of Sleep Research

View full text Add to dashboard Cite

The aim of this study was to determine the neurocognitive and neuropsychiatric effects of continuous positive airway pressure treatment on patients with obstructive sleep apnea. This cross‐sectional, prospective, observational study included 126 patients with sleep apnea. The following tests were performed: the Montreal Cognitive Assessment for the evaluation of cognitive impairment, the Beck Depression Inventory, and the State‐Trait Anxiety Inventory, together with the Epworth Sleepiness Scale for the evaluation of neuropsychiatric symptoms and a person's general level of daytime sleepiness. The first measurement did not show neurocognitive impairment or a higher level of depressive and anxiety symptoms in 126 patients with obstructive sleep apnea in comparison to normative standards. After the 3‐month treatment indicated for 43 patients with obstructive sleep apnea, we did not find any significant improvement in cognitive performance (p = .213). However, patients with sleep apnea with continuous positive airway pressure treatment did show significantly less daytime sleepiness, anxiety and depressive symptoms (all p < .001). In conclusion, short‐term (3 months) treatment of patients with obstructive sleep apnea can substantially alleviate their daytime sleepiness, as well as depressive and anxiety symptoms.

show abstract

Section: Discussionmentioning

confidence: 73%

Section: Discussionmentioning

confidence: 98%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea

Dostálová

Kolečkárová

Kuška

et al. 2018

Journal of Sleep Research

View full text Add to dashboard Cite

show abstract

“…Research has shown an association between depressive symptoms and OSA 10. Depressive symptomatology has been documented in 21.5% of patients surveyed for sleep apnea 11. Additionally, a high prevalence of depressive symptoms was detected among individuals with a high likelihood of OSA 12,13.…”

Section: Introductionmentioning

confidence: 99%

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients

Talih¹,

Ajaltouni²,

Tamim

et al. 2017

NDT

View full text Add to dashboard Cite

ObjectivesThis study evaluated the risk of developing obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS) in hospitalized psychiatric patients at the American University of Beirut Medical Center (AUB-MC). Factors associated with OSA and EDS occurrence in this sample were also examined.MethodsThe Berlin questionnaire and the Epworth sleepiness scale; which respectively evaluate OSA and EDS symptoms, were administered to individuals hospitalized at an acute psychiatric treatment unit at the AUB-MC between the dates of January 2014 and October 2016. Additional data collected included general demographics, psychiatric diagnoses, and questionnaires evaluating depression and anxiety symptoms. Statistical analyses utilizing SPSS were performed to determine the prevalence of OSA and EDS, as well as their respective associations with patient profiles.ResultsOur results showed that 39.5% of participants were found to have a high risk of sleep apnea and 9.9% of the participants were found to have abnormal daytime sleepiness. The risk of developing OSA was associated with a higher body mass index (BMI) (P=0.02), and depression severity (patient health questionnaire 9 score) (P=0.01). Increasing severity of depressive symptoms was associated with a higher risk of sleep apnea (P=0.01). BMI (odds ratio [OR] =5.97, 95% confidence interval [CI] 1.89–18.82) and depression severity (OR =4.04, 95% CI 1.80–9.07) were also found to be predictors of OSA. The psychiatric diagnoses of the participants were not found to have a significant association with the risk of sleep apnea.ConclusionThe risk of OSA is increased among hospitalized psychiatric patients, and this condition can have detrimental effects on psychiatric patients. OSA appears to be under-recognized in this population, psychiatrists should screen for OSA in hospitalized psychiatric patients and refer them for diagnostic testing or treatment when indicated.

show abstract

Neurocognitive and Neuropsychological Effects of OSA

Spector

Farrer

2021

Management of Obstructive Sleep Apnea

View full text Add to dashboard Cite

Obstructive sleep apnea (OSA) and clinical depression—prevalence in a sleep center

Cited by 37 publications

References 62 publications

Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea

Effects of continuous positive airway pressure on neurocognitive and neuropsychiatric function in obstructive sleep apnea

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients

Neurocognitive and Neuropsychological Effects of OSA

Contact Info

Product

Resources

About